Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis-Reference-Cited by-同舟云学术

Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis

Published:2021-10-05 Issue:1 Volume:12 Page:154-171
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Schaettler Maximilian O.^ORCID,Richters Megan M.,Wang Anthony Z.,Skidmore Zachary L.^ORCID,Fisk Bryan,Miller Katherine E.,Vickery Tammi L.,Kim Albert H.,Chicoine Michael R.,Osbun Joshua W.^ORCID,Leuthardt Eric C.,Dowling Joshua L.,Zipfel Gregory J.^ORCID,Dacey Ralph G.,Lu Hsiang-Chih,Johanns Tanner M.^ORCID,Griffith Obi L.^ORCID,Mardis Elaine R.^ORCID,Griffith Malachi^ORCID,Dunn Gavin P.

Funder

Damon Runyon Cancer Research Foundation

NIH

V Foundation for Cancer Research

National Institutes of Health

NIH T32 Genome Analysis Training Program

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma;Blood Advances;2024-07-29

2. Long-read sequencing for brain tumors;Frontiers in Oncology;2024-06-10

3. Genetic and Immunological Characterization of Brain Metastases from Solid Cancers;Anticancer Research;2024-04-27

4. Immunotherapy for Brain Tumors: Where We Have Been, and Where Do We Go From Here?;Current Treatment Options in Oncology;2024-04-23

5. Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma;Clinical Cancer Research;2024-04-19